Assess the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease
A Prospective, Multi-center, Randomized, Controlled Clinical Trial, Assessing the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease in Chinese Population With Coronary Heart Disease
Sponsor: R&G Pharma Studies Co.,Ltd.
A NA clinical study on Coronary Stenosis, this trial is completed. The trial is conducted by R&G Pharma Studies Co.,Ltd. and has accumulated 7 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Aug 2019 [monthly]
Active Not Recruiting NA
▶ Show 2 earlier versions
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- R&G Pharma Studies Co.,Ltd.
- ZhuHai Cardionovum Medical Device Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .